Evonik investing €350 million in fermented L-lysine production

In Germany, Evonik reaffirmed their commitment to biotechnology with a plan to invest some €350 million by 2014 to expand its Biolys business. An amino acid used in animal feeds, Biolys is a source of L-lysine produced via fermentation. Investments include construction of new L-lysine plants in Brazil and Russia capable of producing nearly 200,000 metric tons each year as well as a recently finished production expansion to 280,000 metric tons per year at its Blair site in North America.

This entry was posted in Biodiesel Report. Bookmark the permalink.

Leave a Reply